Inventor
DEVINSKY ORRIN
US29 patents
⚠️ This page may combine multiple inventors who share the name “DEVINSKY ORRIN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
GW RES LTD
14 patentsUS11701330B2Jul 18, 2023
Use of cannabinoids in the treatment of epilepsy
GW RES LTD19 citations98
US11633369B2Apr 25, 2023
Use of cannabinoids in the treatment of epilepsy
GW RES LTD26 citations98
US11446258B2Sep 20, 2022
Use of cannabinoids in the treatment of epilepsy
GW RES LTD30 citations98
US11154516B2Oct 26, 2021
Use of cannabinoids in the treatment of epilepsy
GW RES LTD42 citations98
US11154517B2Oct 26, 2021
Use of cannabinoids in the treatment of epilepsy
GW RES LTD38 citations98
US11096905B2Aug 24, 2021
Use of cannabinoids in the treatment of epilepsy
GW RES LTD43 citations98
US10966939B2Apr 6, 2021
Use of cannabinoids in the treatment of epilepsy
GW RES LTD47 citations98
US10849860B2Dec 1, 2020
Use of cannabinoids in the treatment of epilepsy
GW RES LTD49 citations98
US10709671B2Jul 14, 2020
Use of cannabinoids in the treatment of epilepsy
GW RES LTD52 citations98
US10709674B2Jul 14, 2020
Use of cannabinoids in the treatment of epilepsy
GW RES LTD50 citations98
US10603288B2Mar 31, 2020
Use of cannabinoids in the treatment of epilepsy
GW RES LTD49 citations98
US11963937B2Apr 23, 2024
Use of cannabinoids in the treatment of epilepsy
GW RES LTD14 citations95
US11766411B2Sep 26, 2023
Use of cannabinoids in the treatment of epilepsy
GW RES LTD17 citations95
US11357741B2Jun 14, 2022
Use of cannabinoids in the treatment of epilepsy
GW RES LTD33 citations95
GW PHARMA LTD
10 patentsUS10137095B2Nov 27, 2018
Use of cannabinoids in the treatment of epilepsy
GW PHARMA LTD63 citations99
US10111840B2Oct 30, 2018
Use of cannabinoids in the treatment of epilepsy
GW PHARMA LTD67 citations99
US10092525B2Oct 9, 2018
Use of cannabinoids in the treatment of epilepsy
GW PHARMA LTD62 citations99
US9956186B2May 1, 2018
Use of cannabinoids in the treatment of epilepsy
GW PHARMA LTD68 citations99
US9956184B2May 1, 2018
Use of cannabinoids in the treatment of epilepsy
GW PHARMA LTD67 citations99
US9956185B2May 1, 2018
Use of cannabinoids in the treatment of epilepsy
GW PHARMA LTD71 citations99
US9956183B2May 1, 2018
Use of cannabinoids in the treatment of epilepsy
GW PHARMA LTD69 citations99
US9949937B2Apr 24, 2018
Use of cannabinoids in the treatment of epilepsy
GW PHARMA LTD64 citations99
US11311498B2Apr 26, 2022
Use of cannabinoids in the treatment of epilepsy
GW PHARMA LTD34 citations98
US10765643B2Sep 8, 2020
Use of cannabidiol in the treatment of epilepsy
GW PHARMA LTD35 citations94
JAZZ PHARMACEUTICALS RESEARCH UK LTD
3 patentsUS12064399B2Aug 20, 2024
Use of cannabinoids in the treatment of epilepsy
JAZZ PHARMACEUTICALS RESEARCH UK LTD14 citations94
US12318356B2Jun 3, 2025
Use of cannabinoids in the treatment of epilepsy
JAZZ PHARMACEUTICALS RESEARCH UK LTD2 citations86
US12427160B2Sep 30, 2025
Use of cannabinoids in the treatment of epilepsy
JAZZ PHARMACEUTICALS RESEARCH UK LTD1 citations75